These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25261325)

  • 1. Iloprost reverses established fibrosis in experimental right ventricular failure.
    Gomez-Arroyo J; Sakagami M; Syed AA; Farkas L; Van Tassell B; Kraskauskas D; Mizuno S; Abbate A; Bogaard HJ; Byron PR; Voelkel NF
    Eur Respir J; 2015 Feb; 45(2):449-62. PubMed ID: 25261325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
    Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
    J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
    PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
    Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
    Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Right Ventricular Hypertension Induces Regional β1-Integrin-Mediated Transduction of Hypertrophic and Profibrotic Right and Left Ventricular Signaling.
    Sun M; Ishii R; Okumura K; Krauszman A; Breitling S; Gomez O; Hinek A; Boo S; Hinz B; Connelly KA; Kuebler WM; Friedberg MK
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29599211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.
    Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
    Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
    Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
    van Albada ME; Berger RM; Niggebrugge M; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG
    Eur J Pharmacol; 2006 Nov; 549(1-3):107-16. PubMed ID: 16978602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
    Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
    Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
    Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
    Alzoubi A; Toba M; Abe K; O'Neill KD; Rocic P; Fagan KA; McMurtry IF; Oka M
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1708-18. PubMed ID: 23585128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats.
    He YY; Liu CL; Li X; Li RJ; Wang LL; He KL
    Vascul Pharmacol; 2016 Dec; 87():190-198. PubMed ID: 27678416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.